Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway
In this study, we investigated the therapeutic effects and mechanism of atractylodin (ATL) on dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We found that atractylodin could significantly reverse the effects of DSS-induced ulcerative colitis, such as weight loss, disease activity i...
Main Authors: | Linghang Qu, Xiong Lin, Chunlian Liu, Chang Ke, Zhongshi Zhou, Kang Xu, Guosheng Cao, Yanju Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.665376/full |
Similar Items
-
Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
by: Qingyan Ye, et al.
Published: (2023-07-01) -
Atractylodin Ameliorates Colitis via PPARα Agonism
by: Gwangbeom Heo, et al.
Published: (2023-01-01) -
Atractylodin ameliorates bleomycin-induced pulmonary inflammation and fibrosis in mice
by: Zhenhui Wu, et al.
Published: (2023-09-01) -
Anti-inflammatory, antioxidant and anti-virulence roles of atractylodin in attenuating Listeria monocytogenes infection
by: Lei Xu, et al.
Published: (2022-10-01) -
Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions
by: Artitaya Thiengsusuk, et al.
Published: (2023-03-01)